Danielle Greenawalt

Danielle received her PhD in Molecular Genetics, followed by a post-doctoral fellowship at the Peter MacCallum Cancer Centre in Melbourne, Australia. She began her computational research career in industry at Merck, spending 5 years leading pharmacogenetic analysis in oncology, CV & diabetes and developing internal NGS capabilities. She then spent 3 years at AstraZeneca as the Global lead of Target ID Oncology Informatics, translating patient data into oncology targets through novel informatics approaches. Danielle currently leads a team of computational biologists within the Translational Informatics & Predictive Sciences team at Bristol Myers Squibb focused on deriving novel insights from large scale translational disease and clinical datasets to advance our drug development pipeline.